Monitoring of Serum Squamous Cell Carcinoma Antigen Levels in Invasive Cervical Cancer: Is It Cost-Effective?
- 31 January 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 84 (1) , 7-11
- https://doi.org/10.1006/gyno.2001.6497
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.Journal of Clinical Oncology, 1996
- Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervixGynecologic Oncology, 1990
- Use of serum squamous cell carcinoma antigen assays in chemotherapy treatment of cervical cancerGynecologic Oncology, 1989
- Value of squamous cell carcinoma antigen levels in invasive cervical carcinomaGynecologic Oncology, 1989
- Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervixCancer, 1989
- An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinomaAmerican Journal of Obstetrics and Gynecology, 1987
- Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial Determinations and Tissue LocalizationCancer, 1985
- Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinomaCancer, 1984
- Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancerCancer, 1982
- Tumor antigen of human cervical squamous cell carcinoma.Correlation of circulating levels with disease progressCancer, 1979